Virus therapy targets deadly brain tumors in new trial
NCT ID NCT07126990
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 31 times
Summary
This study tests a new treatment for a fast-growing type of brain tumor called high-grade glioma. The treatment uses a specially designed virus that targets and attacks tumor cells. The study will include 40 adults aged 18-80 who have not yet received any other cancer treatment. The main goal is to see how many patients are alive 12 months after receiving the virus.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sanbo Brain Hospital, Capital Medical University
Beijing, Chaoyang District, China
Conditions
Explore the condition pages connected to this study.